Massive global study aims to unlock secrets of severe pneumonia care
NCT ID NCT07301099
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study will track over 2,500 adults hospitalized with severe community-acquired pneumonia across dozens of countries. Researchers will collect data from medical records to see how closely hospitals follow international treatment guidelines and what factors lead to better or worse outcomes. No new drugs or procedures are being tested — the goal is simply to learn from real-world care to improve future treatment and survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors worldwide improve how they diagnose and treat severe pneumonia, potentially saving more lives.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly cure or prevent pneumonia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clínica Universidad de La Sabana
Chía, Colombia
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact